Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Building the Lab of the Future Through AI, ML & Cultural Change Christos Varsakelis at The Janssen Pharmaceutical Companies of Johnson & Johnson Production of data is a costly business for Biopharma, always under scrutiny, and this is highly unlikely to change. On the other hand, AI/ML is de f... March 23, 2023 2:00pm End-to-End Single-Use Manufacturing at Pilot Plant for Early Development... Agnieszka Önder , DS Operations Pilot Plant Leiden at The Janssen Pharmaceutical Companies of Johnson & Johnson Full title: End-to-End Single-Use Manufacturing at Pilot Plant for Early Development Clinical Material The Single Use Item within the Pharmaceutical ... 7 days ago | 26 mins Enabling Robust Biomanufacturing Through Systematic Understanding of Single-Use Dr. Jun Tian, Executive Director and Head of Upstream Process Development at WuXi Biologics Full title: Enabling Robust Biomanufacturing Through Systematic Understanding of Single-Use Systems and Stringent Process and Raw Material Controls S... 4 weeks ago | 43 mins Challenges And Opportunities Of Continuous Bioprocessing And Risk Management Sethu Madhavan, Global Head of Insulin Operations at Biocon Biologics -Migrating Bioprocessing into the Existing Infrastructure with Carefully Controlled Risk Management Systems -Addressing The Opportunities and Challen... April 27, 2023 8:30am Chromatography Based Near-Real-Time Measurements & Timely Control... Letha Chemmalil, at BMS, Magnus Wetterhall and Nick Pittman at Waters Full title: Chromatography Based Near-Real-Time Measurements & Timely Control of Product Titer, Product Quality and Cell Culture Nutrients PAT has be... 4 weeks ago | 119 mins GMP Implementation of Continuous Manufacturing: A case study Neil Soice at Amgen, Inc. and Michael Phillips at Merck Continuous processing is being explored in various ways throughout the biopharmaceutical industry. New process technologies and business consideratio... April 18, 2023 2:00pm Harmonized Manufacturing Network For Sterility Assurance Frederic Ayers at Eli Lilly and Company, Martell Winters at Nelson Labs and John Schlect at Sterigenics This presentation will provide an understanding related to Global Guidance related to holistic Contamination Control Strategies. The importance of cr... 1 month ago | 142 mins Technologies and Platform Approach for Optimizing Downstream Purification... Ashish Saksule at Vertex Pharmaceuticals and Dr Alejandro Becerra at Thermo Fisher Scientific Full title: Technologies and Platform Approach for Optimizing Downstream Purification of Viral Vectors The promising success stories and advancement ... May 10, 2023 2:00pm The exogenously driven disruption of Bioprocessing Christos Varsakelis, at The Janssen Pharmaceutical Companies of J&J and Pranjul Mishra, at Yokogawa Insilico Biotechnology Industry 4.0 comes with an impressive collection of assets and capabilities. However, although the degree of applicability in Bioprocessing is high, t... 6 months ago | 72 mins Mass Transport Modelling in support of leachable risk management. Thomas Egert at Boehringer Ingelheim Pharma and Jason Creasey at Maven E&L Ltd Leachable risk management continues to be of regulatory interest. However we continue to rely on experimental extractable studies as predictors of lea... 2 months ago | 103 mins Load more
